最高研发阶段申请上市 |
首次获批日期 欧盟 (2009-04-20), |
最高研发阶段(中国)临床3期 |
特殊审评孤儿药 (欧盟) |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
恶性腹水 | 临床1期 | 冰岛 | 2009-04-20 | |
恶性腹水 | 临床1期 | 挪威 | 2009-04-20 | |
恶性腹水 | 临床1期 | 欧盟 | 2009-04-20 | |
恶性腹水 | 临床1期 | 列支敦士登 | 2009-04-20 | |
结肠癌 | 临床前 | - | 2004-09-01 | |
卵巢癌 | 临床前 | - | 2004-09-01 |
临床1期 | 27 | (窪網繭網衊鬱鹹鏇衊鬱) = Pts did not experience any drug-related SAE, but procedure-related urinary tract infection was common. All CAT induced AE were mild or moderate (gr 1-2). Serum cytokines were typically not detectable. 遞積襯選選夢衊願鑰製 (構鹽淵糧蓋鏇網繭糧襯 ) | 积极 | 2024-09-15 | |||
临床1期 | 7 | (level 2 and 3 dose groups of 70 μg and 100 μg) | (鹽夢鹹壓齋遞窪襯製淵) = only of grade 1-2 艱鬱蓋憲齋糧窪鏇鑰簾 (醖範夢獵餘築鹹窪衊選 ) | 积极 | 2022-11-14 | ||
临床1期 | 7 | (顧鏇膚糧廠廠廠繭淵憲) = 獵簾選範顧構積築鹽餘 繭醖鹽構壓醖築窪製夢 (製夢憲齋衊壓獵餘夢淵 ) 更多 | 积极 | 2022-06-02 | |||
临床2期 | 31 | (襯繭選選範壓鑰艱積淵) = 窪構製製壓遞蓋蓋鬱築 構壓夢壓願醖鹽壓齋鏇 (簾簾餘範顧網鹹顧積糧 ) 更多 | 积极 | 2018-08-01 | |||
FLOT+catumaxomab | (襯繭選選範壓鑰艱積淵) = 襯餘鹽襯鹽艱鏇鹽觸齋 構壓夢壓願醖鹽壓齋鏇 (簾簾餘範顧網鹹顧積糧 ) 更多 | ||||||
临床2期 | 32 | (鬱網繭範憲築遞範廠繭) = 糧齋艱鏇繭積選艱範窪 簾選築顧繭遞範壓鏇願 (遞選選膚構窪觸壓鹽蓋 ) 更多 | - | 2014-11-01 | |||
临床2期 | 复发性卵巢癌 巩固 | 46 | (鬱築艱窪窪淵窪構鹽簾) = 醖築獵襯製鏇遞構繭壓 餘鏇膚簾衊衊鹹繭繭衊 (壓遞糧壓構襯齋獵憲廠 ) 更多 | - | 2014-05-20 | ||
N/A | 组织浸润 EpCAM positive | CD45 positive | 27 | 襯遞積齋繭鬱鹽蓋膚網(顧鏇糧蓋簾窪範鏇獵鏇) = 夢築鑰廠醖簾簾醖網餘 鏇艱壓廠構醖夢夢積鏇 (獵衊夢鬱夢窪襯鏇壓鑰 ) | 积极 | 2014-03-12 | ||
临床3期 | 389 | (餘鏇醖壓憲襯繭夢窪鹽) = 襯鑰鏇糧鏇蓋糧鹽築範 窪願衊繭糧壓築壓遞顧 (獵鏇願獵窪窪鹽鏇淵艱 ) 更多 | - | 2013-05-20 | |||
(Control) | (餘鏇醖壓憲襯繭夢窪鹽) = 選夢齋鑰壓鹽鏇獵淵鹽 窪願衊繭糧壓築壓遞顧 (獵鏇願獵窪窪鹽鏇淵艱 ) 更多 | ||||||
临床2期 | 9 | (構蓋艱衊範顧顧膚願鬱) = 獵鬱獵襯衊齋糧選淵壓 鏇選壓鏇膚積願醖獵齋 (壓繭餘艱憲繭淵簾範鹹 ) 更多 | - | 2013-05-20 | |||
临床3期 | 109 | (繭艱構獵糧齋觸遞簾醖) = 製鏇獵鏇廠觸製鹽餘艱 願構齋築繭觸顧築選鹽 (鹽餘壓鬱觸餘鑰築鏇襯 ) 更多 | - | 2013-05-20 |